ADAPTHEALTH CORP. ANNOUNCES SECOND QUARTER 2021 FINANCIAL RESULTS Plymouth Meeting, PA

ADAPTHEALTH CORP. ANNOUNCES SECOND QUARTER

2021 FINANCIAL RESULTS

Plymouth Meeting, PA - August 5, 2021 - AdaptHealth

Corp. (NASDAQ: AHCO) ("AdaptHealth" or the "Company"), a national leader in providing patient-centered, healthcare-at-home

solutions including home medical equipment, medical supplies, and related services, announced today

financial results for the second quarter ended June 30, 2021.

Second Quarter Results

Based on current business and market trends, the Company is increasing

its previously issued financial guidance for fiscal year 2021 as follows:

Management Commentary

Steve Griggs, Chief Executive Officer, commented, "We are very

pleased with our financial results this quarter which were driven by the outstanding efforts of our combined team. Our results were largely

driven by a full quarter of AeroCare and realization of integration synergies. Our business continues to grow organically as well as

through strategic acquisitions in key markets which complement our national platform. In the second quarter we acquired several excellent

businesses including Spiro Health Services, a provider of home medical equipment and supplies, and Healthy Living Medical Supplies, a

provider of continuous glucose monitors and insulin pumps which strategically expands our diabetes footprint in the Midwest."

Mr. Griggs continued, "It has been six months since the acquisition

of AeroCare, and we have already achieved many of the ambitious goals we set out to accomplish including improving patient access, patient

experience, and clinical outcomes. With these goals in mind, we continue to execute on our strategy of organic growth, improving operations,

and closing accretive acquisitions."

Josh Parnes, President, commented, "We

have made great progress towards our strategic roadmap within operational technologies and chronic disease management to enhance our overall

business. As an example, we are very pleased with the results of our e-prescribe technology in diabetes which has improved patient and

provider satisfaction through reduced cycle time. While we are very excited in the results we've already seen, we're even

more optimistic about our continued transformation journey towards improving patient outcomes and reducing the overall cost of care."

Management will host a conference at 8:30 am ET

today to discuss the results and business activities. Interested parties may participate in the call by dialing:

Webcast registration: Click Here

Following the live call, a replay will be available for six months

on the Company's website, www.adapthealth.com under "Investor Relations."

About AdaptHealth Corp.

AdaptHealth is a national leader in providing patient-centered, healthcare-at-home

solutions including home medical equipment, medical supplies, and related services. AdaptHealth provides a full suite of medical products

and solutions designed to help patients manage chronic conditions in the home, adapt to life and thrive. Product and services offerings

include (i) sleep therapy equipment, supplies and related services (including CPAP and bi PAP services) to individuals suffering from

obstructive sleep apnea, (ii) medical devices and supplies to patients for the treatment of diabetes (including continuous glucose monitors

and insulin pumps), (iii) home medical equipment (HME) to patients discharged from acute care and other facilities, (iv) oxygen and related

chronic therapy services in the home, and (v) other HME medical devices and supplies on behalf of chronically ill patients with wound

care, urological, incontinence, ostomy and nutritional supply needs. The Company is proud to partner with an extensive and highly diversified

network of referral sources, including acute care hospitals, sleep labs, pulmonologists, skilled nursing facilities, and clinics. AdaptHealth

services beneficiaries of Medicare, Medicaid and commercial insurance payors. AdaptHealth services approximately 3.3 million patients annually

in all 50 states through its network of 678 locations in 47 states. Learn more at www.adapthealth.com.

Forward-Looking Statements

This press release includes certain statements that are not historical

facts but are forward-looking statements for purposes of the safe harbor provisions under the United States Private Securities Litigation

Reform Act of 1995. Forward-looking statements generally are accompanied by words such as "believe," "may," "will,"

"estimate," "continue," "anticipate," "intend," "expect," "should,"

"would," "plan," "predict," "potential," "seem," "seek," "future,"

"outlook," and similar expressions that predict or indicate future events or trends or that are not statements of historical

matters. These forward-looking statements include, but are not limited to, statements regarding projections, estimates and forecasts of

revenue and other financial and performance metrics and projections of market opportunity and expectations and the Company's acquisition

pipeline. These statements are based on various assumptions and on the current expectations of AdaptHealth management and are not predictions

of actual performance. These forward-looking statements are provided for illustrative purposes only and are not intended to serve as,

and must not be relied on, by any investor as, a guarantee, an assurance, a prediction or a definitive statement of fact or probability.

Actual events and circumstances are difficult or impossible to predict and will differ from assumptions. Many actual events and circumstances

are beyond the control of the Company.

These forward-looking statements are subject to a number of risks and

uncertainties, including the outcome of judicial and administrative proceedings to which the Company may become a party or governmental

investigations to which the Company may become subject that could interrupt or limit the Company's operations, result in adverse

judgments, settlements or fines and create negative publicity; changes in the Company's clients' preferences, prospects and

the competitive conditions prevailing in the healthcare sector; and the impact of the recent coronavirus (COVID-19) pandemic and the Company's

response to it. A further description of such risks and uncertainties can be found in the Company's filings with the Securities

and Exchange Commission. If the risks materialize or assumptions prove incorrect, actual results could differ materially from the results

implied by these forward-looking statements. There may be additional risks that the Company presently knows or that the Company currently

believes are immaterial that could also cause actual results to differ from those contained in the forward-looking statements. In addition,

forward-looking statements reflect the Company's expectations, plans or forecasts of future events and views as of the date of this

press release. The Company anticipates that subsequent events and developments will cause the Company's assessments to change. However,

while the Company may elect to update these forward-looking statements at some point in the future, the Company specifically disclaims

any obligation to do so. These forward-looking statements should not be relied upon as representing the Company's assessments as

of any date subsequent to the date of this press release. Accordingly, undue reliance should not be placed upon the forward-looking statements.

Use of Non-GAAP Financial Information and Financial Guidance

This release contains non-GAAP financial guidance, which is adjusted

to exclude certain costs, expenses, gains and losses and other specified items that are evaluated on an individual basis. These non-GAAP

items are adjusted after considering their quantitative and qualitative aspects and typically have one or more of the following characteristics,

such as being highly variable, difficult to project, unusual in nature, significant to the results of a particular period or not indicative

of future operating results. Similar charges or gains were recognized in prior periods and will likely reoccur in future periods.

The Company uses EBITDA, Adjusted EBITDA and Adjusted EBITDA less

Patient Equipment Capex, which are financial measures that are not prepared in accordance with generally accepted accounting

principles in the United States, or U.S. GAAP, to analyze its financial results and believes that they are useful to investors, as a

supplement to U.S. GAAP measures. In addition, the Company's ability to incur additional indebtedness and make investments

under its existing credit agreement is governed, in part, by its ability to satisfy tests based on a variation of Adjusted EBITDA

less Patient Equipment Capex.

The Company believes Adjusted EBITDA less Patient Equipment Capex is

useful to investors in evaluating the Company's financial performance. The Company's business requires significant investment

in equipment purchases to maintain its patient equipment inventory. Some equipment title transfers to patients' ownership after

a prescribed number of fixed monthly payments. Equipment that does not transfer wears out or often times is not recovered after a patient's

use of the equipment terminates. The Company uses this metric as the profitability measure in its incentive compensation plans that have

a profitability component and to evaluate acquisition opportunities, where it is most often used for purposes of contingent consideration

arrangements. In addition, the Company's debt agreements contain covenants that use a variation of Adjusted EBITDA less Patient

Equipment Capex for purposes of determining debt covenant compliance. For purposes of this metric, patient equipment capital expenditure

is measured as the value of the patient equipment received during the accounting period without regard to whether the equipment is purchased

or financed through lease transactions.

EBITDA, Adjusted EBITDA and Adjusted EBITDA less Patient Equipment

Capex should not be considered as measures of financial performance under U.S. GAAP, and the items excluded from EBITDA, Adjusted EBITDA

and Adjusted EBITDA less Patient Equipment Capex are significant components in understanding and assessing financial performance. Accordingly,

these key business metrics have limitations as an analytical tool. They should not be considered as an alternative to net income or any

other performance measures derived in accordance with U.S. GAAP or as an alternative to cash flows from operating activities as a measure

of the Company's liquidity.

There is no reliable or reasonably estimable comparable GAAP measure

for the Company's non-GAAP financial guidance because the Company is not able to reliably predict the impact of certain items, including